Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

Investing

AbbVie : ABBV

All AbbVie Articles

601 Articles

Jon C. Ogg | Oct 23, 2015 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

Friday's top analyst upgrades, downgrades and initiations include AbbVie, Alphabet, Amazon.com, American Electric Power, Apple, Microsoft, Pandora Media and McDonald's.

Chris Lange | Oct 22, 2015 at 4:31 PM EDT

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause…

Lee Jackson | Oct 12, 2015 at 10:15 AM EDT

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.

Chris Lange | Oct 12, 2015 at 9:25 AM EDT

Short Sellers Become More Selective on Major Pharma

The September 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Oct 5, 2015 at 8:20 AM EDT

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Credit Suisse is adding some top conservative dividend-paying stocks to its Top Picks list, and that is right in line…

Chris Lange | Sep 25, 2015 at 8:40 AM EDT

Short Sellers Boost Positions in Major Pharma

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Sep 11, 2015 at 8:25 AM EDT

Short Sellers Become More Selective in Major Pharma

The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…

Chris Lange | Sep 10, 2015 at 4:18 PM EDT

AbbVie Posts Another Win for Humira

ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…

Chris Lange | Aug 26, 2015 at 8:05 AM EDT

Short Sellers Have Mixed Feelings on Major Pharma

The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | Aug 18, 2015 at 8:22 AM EDT

4 Top Pharma Stocks That Should Outperform Out To 2016

ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…

Chris Lange | Aug 12, 2015 at 9:45 AM EDT

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 10, 2015 at 3:19 PM EDT

Why AbbVie Should Be Worth 25% More

Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Chris Lange | Jul 24, 2015 at 9:10 AM EDT

Are AbbVie Earnings Enough?

AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.

Chris Lange | Jul 23, 2015 at 1:25 PM EDT

What to Expect From AbbVie Earnings

Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.

1 … 33 34 35 36 37 … 41

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

AbbVie Posts Another Win for Humira

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Short Sellers Back Off Big Pharma

Why AbbVie Should Be Worth 25% More

Short Sellers Run For Cover From Major Pharma

Are AbbVie Earnings Enough?

What to Expect From AbbVie Earnings

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

“This Is Money Going to the Past”: Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife’s House

What It Takes to Retire on the Emerald Coast in Destin, Florida, at 63 on $950,000

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits

"This Is Money Going to the Past": Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife's House

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

“This Is Money Going to the Past”: Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife’s House

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Alphabet, Amazon, Apple, Microsoft, Pandora, McDonald’s, Many More

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends

Short Sellers Become More Selective on Major Pharma

Credit Suisse Adds Blue Chip Dividend Stocks to Prestigious Top Picks List

Short Sellers Boost Positions in Major Pharma

Short Sellers Become More Selective in Major Pharma

AbbVie Posts Another Win for Humira

Short Sellers Have Mixed Feelings on Major Pharma

4 Top Pharma Stocks That Should Outperform Out To 2016

Short Sellers Back Off Big Pharma

Why AbbVie Should Be Worth 25% More

Short Sellers Run For Cover From Major Pharma

Are AbbVie Earnings Enough?

What to Expect From AbbVie Earnings

Live: Will Micron Crush Q3 Earnings Tonight After Tuesday’s 13% Selloff?

91% of Retirees Fail to Make the “Strongest Move” for Social Security Benefits

“This Is Money Going to the Past”: Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife’s House

What It Takes to Retire on the Emerald Coast in Destin, Florida, at 63 on $950,000

Featured Reads

91% of Retirees Fail to Make the "Strongest Move" for Social Security Benefits

"This Is Money Going to the Past": Dave Ramsey to a 43-Year-Old With a $950K Net Worth Who Wants to Pay Off His Ex-Wife's House